NEW YORK (GenomeWeb News) - Nanobiosym, a Massachusetts company that is developing a diagnostic tool that blends nanotechnology and genomics, said on Friday that it has received a $2 million contract from the United States Defense Threat Reduction Agency.

 

The company plans to use the contract to validate the use of its technology, called Gene-RADAR, which it has been developing with its commercial partner, Nanobiosym Diagnostics.